Faculty, Staff and Student Publications

Publication Date

4-5-2022

Journal

Cell Metabolism

Abstract

Asprosin is a fasting-induced glucogenic and centrally acting orexigenic hormone. The olfactory receptor Olfr734 is known to be the hepatic receptor for asprosin that mediates its effects on glucose production, but the receptor for asprosin's orexigenic function has been unclear. Here, we have identified protein tyrosine phosphatase receptor δ (Ptprd) as the orexigenic receptor for asprosin. Asprosin functions as a high-affinity Ptprd ligand in hypothalamic AgRP neurons, regulating the activity of this circuit in a cell-autonomous manner. Genetic ablation of Ptprd results in a strong loss of appetite, leanness, and an inability to respond to the orexigenic effects of asprosin. Ablation of Ptprd specifically in AgRP neurons causes resistance to diet-induced obesity. Introduction of the soluble Ptprd ligand-binding domain in the circulation of mice suppresses appetite and blood glucose levels by sequestering plasma asprosin. Identification of Ptprd as the orexigenic asprosin receptor creates a new avenue for the development of anti-obesity therapeutics.

Keywords

Agouti-Related Protein, Animals, Fibrillin-1, Glucose, Ligands, Mice, Obesity, Peptide Fragments, Peptide Hormones, Receptor-Like Protein Tyrosine Phosphatases, Class 2, Asprosin, receptor, Ptprd, AgRP, metabolism, obesity

DOI

10.1016/j.cmet.2022.02.012

PMID

35298903

PMCID

PMC8986618

PubMedCentral® Posted Date

4-5-2023

PubMedCentral® Full Text Version

Author MSS

Published Open-Access

yes

nihms-1786674-f0008.jpg (197 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.